Meet our partner – HansaBioMed Life Sciences
MARVEL project consortium consists of 7 partners (CNR-SCITEC, CNR-ITM, Istituto Cardiocentro Ticino, Vita-Salute San Raffaele University, HansaBioMed Life Sciences, Paperdrop Diagnostics, Amires) and each of them provides unique competence and complementary expertise. Collectively, they cover the whole spectrum of skills required for the development of a multifaceted and versatile platform enabling scalable Extracellular Vesicles (EVs) isolation in various contexts of EVs research and deployment, in diagnostics and therapy.
Today, we would like to introduce one of our partners, HansaBioMed Life Sciences. The company is entirely dedicated to the research and development of products in the field of exosome sciences. Their mission is to develop and commercialize proprietary platforms, kits, reagents, and equipment for exosome research in the Life Science market. HansaBioMed collaborates with various international research groups, both Academic and Industrial, and participates in research projects, such as the MARVEL project.
Watch a short interview with one of the HansaBioMed representatives Dr. Natasa Zarovni to know more about HansaBioMed, their involvement in the MARVEL project, and current challenges and horizons in Extracellular Vesicles research.